Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2025-12-24 @ 4:13 PM
Study NCT ID:
NCT02923466
Status:
COMPLETED
Last Update Posted:
2022-04-27
First Post:
2016-09-30
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Ph1 Administration of VSV-IFNβ-NIS Monotherapy and in Combination With Avelumab in Pts With Refractory Solid Tumors
Sponsor:
Vyriad, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-04-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-02-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-04-22
Completion Date Type:
ACTUAL
First Submit Date:
2016-09-30
First Submit QC Date:
None
Study First Post Date:
2016-10-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-25
Last Update Post Date:
2022-04-27
Last Update Post Date Type:
ACTUAL